Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.

Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value ...

PLX READ THE FULL PLX RESEARCH REPORT 2025 Financial and Operational Review Protalix BioTherapeutics, Inc. (NYSE: PLX) ...

CEO Garry Neil said the company expects to report top-line data in the second quarter from its completed Phase 2b LOTUS trial ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...

Rapport Therapeutics, Inc. ( RAPP) Stifel 2026 Virtual CNS Forum March 17, 2026 9:30 AM EDT Great. Good morning, everybody. Happy to be here, moderating this panel with Abe Ceesay, CEO of Rapport ...

NVIDIA's biggest DLSS announcement yet brings dynamic frame generation to RTX 50 Series cards March 31st. Twenty games confirmed including 007 First Light and CONTROL Resonant, plus major Witcher 4 ...

NVIDIA is making its presence known at GDC 2025, kicking things off with some updates to its RTX Remix tech. While RTX Remix has been available in open beta form since January 2024, part of today's ...

Detailed price information for Plus Therapeutics Inc (PSTV-Q) from The Globe and Mail including charting and trades.

The dominant paradigm of metabolic treatment has long operated within a narrow frame: reduce caloric intake, increase caloric expenditure, manage the consequences. That framework is now obsolete. The ...